Organogenesis Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript
Welcome to another session. I'm Drew Ranieri one of the medical device analyst here at Morgan Stanley. And I'm delighted to have members of the Organogenesis management team with us here today. Gary the CEO and Dave, the CFO. Maybe just before we kind of jump in I have to read the quick disclaimer but for important disclosures please see the Morgan Stanley Research disclosure website at morganstanley.com/researchdisclosures. And if you do have any other questions, please reach out to your Morgan Stanley sales rep. With that let's kind of kick it off. And Gary, maybe just spend a couple of minutes to kind of give some introductory comments and really set the stage for where the company plays its markets and really the growth opportunities that you see for the company?
Questions & Answers
Appreciate the opportunity. So Organogenesis, we're a med tech company. Primarily our technology is in the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
